IL37 and susceptibility to pneumonia measurement: In conclusion, these data provide evidence that IL-37 inhibits the pathogenesis of influenza pneumonia by decreasing the production of essential pro-inflammatory cytokines, indicating a new and promising therapeutic approach for excessively activated immune responses in influenza A infection-induced pneumonia.